Attached files
| file | filename |
|---|---|
| S-1 - S-1 - Global Blood Therapeutics, Inc. | d885656ds1.htm |
| EX-10.10 - EX-10.10 - Global Blood Therapeutics, Inc. | d885656dex1010.htm |
| EX-10.4 - EX-10.4 - Global Blood Therapeutics, Inc. | d885656dex104.htm |
| EX-10.7 - EX-10.7 - Global Blood Therapeutics, Inc. | d885656dex107.htm |
| EX-4.2 - EX-4.2 - Global Blood Therapeutics, Inc. | d885656dex42.htm |
| EX-10.5 - EX-10.5 - Global Blood Therapeutics, Inc. | d885656dex105.htm |
| EX-10.11 - EX-10.11 - Global Blood Therapeutics, Inc. | d885656dex1011.htm |
| EX-10.1 - EX-10.1 - Global Blood Therapeutics, Inc. | d885656dex101.htm |
| EX-10.3 - EX-10.3 - Global Blood Therapeutics, Inc. | d885656dex103.htm |
| EX-3.1 - EX-3.1 - Global Blood Therapeutics, Inc. | d885656dex31.htm |
| EX-3.3 - EX-3.3 - Global Blood Therapeutics, Inc. | d885656dex33.htm |
| EX-10.9 - EX-10.9 - Global Blood Therapeutics, Inc. | d885656dex109.htm |
| EX-10.6 - EX-10.6 - Global Blood Therapeutics, Inc. | d885656dex106.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Global Blood Therapeutics, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
July 8, 2015